Moneycontrol
HomeNewsVideosBusinessStocksAmi Organics | Growing interest of innovators in this pharma intermediates player| Stock of the Day

Ami Organics | Growing interest of innovators in this pharma intermediates player| Stock of the Day

Ami Organics gets 79 percent of the revenue comes from pharma space wherein it manufactures intermediates for APIs and NCE (New Chemical Entities). Rest of the revenue comes from chemicals segment. While company’s foray into the lithium-ion batteries and the semiconductor industry value chain is a key watch, ramp-up in CDMO (Contract Development and Manufacturing Organization) contracts is expected to be the key earnings catalyst.

January 08, 2025 / 08:01 IST
Story continues below Advertisement

Moneycontrol News
first published: Jan 8, 2025 08:00 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!